Oculis Appoints Mark Kupersmith and Sebastian Wolf, as Chief Medical Advisors
August 25, 2025
Oculis Holding AG, a global biopharmaceutical company focused on innovations addressing ophthalmic and neuro-ophthalmic diseases with significant unmet medical needs, announced the appointments of Mark